Randomized controlled trial to examine efficacy on body fat reduction and safety of amino acid mixture during physical activity promotion in overweight adults

Randomized controlled trial to examine efficacy on body fat reduction and safety of amino acid mixture during physical activity promotion in overweight adults - Efficacy of amino acid mixture during physical activity promotion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025186

Enrollment

200

Registered

2016-12-10

Start date

2017-01-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Interventions

4 physical activity sessions and daily intake of placebo drink for 3 months 4 physical activity sessions and daily intake of test drink for 3 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Body mass index is 25 or more but less than 30 at the screening measurement 2. Individuals who understand the purpose and contents of the study, have ability to provide written consent, and give the written informed consent form

Exclusion criteria

Exclusion criteria: 1. Constant use of oral medication potentially affecting body weight and lipid metabolism 2. Those who have severe hepatic disorder, cardiovascular disorder, breathing disorder, endocrine disorder, metabolism disorder, or food allergy 3. Those who cannot stop use of health food products or supplements potentially affecting body weight and lipid metabolism 4. Current or past history of drug or alcohol dependence 5. Those who cannot abstain from alcohol drinking for 2 days before measurements 6. Those who have some metal implanted in their abdominal site 7. With cardiac pacemaker or implanted defibrillator 8. Diagnosed with phenylketonuria or hyperphenylalaninemia 9. Diagnosed with familial hyperlipidemia 10. Those who are currently pregnant or nursing or desire pregnancy during the study 11. Those who have extremely irregular dietary habits or lifecycle such as midnight work 12. Those who participate or are willing to participate clinical trials of other food products, drugs, or beauty products. 13. Those who have claustrophobia 14. Those who are judged as unsuitable for the study by the principal investigator for other reasons

Design outcomes

Primary

Measure	Time frame
3-month changes in abdominal fat areas	—

Secondary

Measure	Time frame
3-month changes in body weight, percent body fat, waist circumference, hip circumference, waist-hip ratio, blood pressure, BMI, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting plasma glucose, HbA1c, insulin, and HOMA-R	—

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales Department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026